Search Count: 8
 |
Synthesis And Biological Evaluation Of Novel Selective Androgen Receptor Modulators (Sarms): Part Iii
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2017-05-24 Classification: SIGNALING PROTEIN Ligands: GOL, 97A |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-05-24
Ligands: GOL, 97A
 |
Synthesis And Biological Evaluation Of Novel Selective Androgen Receptor Modulators (Sarms). Part Ii: Optimization Of 4-(Pyrrolidin-1-Yl)Benzonitrile Derivatives
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.71 Å Release Date: 2017-04-26 Classification: HORMONE RECEPTOR Ligands: GOL, 77U |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-04-26
Ligands: GOL, 77U
 |
Synthesis And Biological Evaluation Of Novel Selective Androgen Receptor Modulators (Sarms). Part Ii: Optimization Of 4-(Pyrrolidin-1-Yl)Benzonitrile Derivatives
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2017-04-26 Classification: HORMONE RECEPTOR Ligands: GOL, 77T |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-04-26
Ligands: GOL, 77T
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With N-Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2017-01-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NA, EDO, WMM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-18
Ligands: ZN, CA, NA, EDO, WMM
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With 4-Oxo-N-(3-(2-(1H-1,2,4-Triazol-3-Ylsulfanyl)Ethoxy)Benzyl)-3,4-Dihydroquinazoline-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2017-01-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, WNN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-18
Ligands: ZN, CA, WNN
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With 4-(2-((6-Fluoro-2-((3-Methoxybenzyl)Carbamoyl)-4-Oxo-3,4-Dihydroquinazolin-5-Yl)Oxy)Ethyl)Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2015-05-20 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NA, FMT, WHH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-05-20
Ligands: ZN, CA, NA, FMT, WHH
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydroquinazoline-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2014-09-24 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NA, WGG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-09-24
Ligands: ZN, CA, NA, WGG
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2014-09-24 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NA, FMT, EDO, WLL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-09-24
Ligands: ZN, CA, NA, FMT, EDO, WLL